Ether

Ether

SCHEMBL6738747

CCOCC.[Li]c1cccc2c1Cc1ccccc1-2

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.46
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
HTR7 P34969 1/20 0.35
HTR2B P41595 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35
GABRE P78334 1/20 0.35
GABRA6 Q16445 1/20 0.35
GABRG1 Q8N1C3 1/20 0.35
GABRG3 Q99928 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL825557 0.86 PNMT (0.53) PNMTNPC1RAB9AHTR7HTR2B
Hexane SCHEMBL8201767 0.85 PNMT (0.47) PNMTNPC1RAB9AHTR7HTR2B
Ether SCHEMBL9618978 0.81 PNMT (0.46) PNMTNPC1RAB9AHTR7HTR2B
Fluorene SCHEMBL4847437 0.80 MAOA (0.48) PNMTNPC1RAB9AHTR2BGABRP
SCHEMBL1275883 0.77 PNMT (0.58) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL9073162 0.75 PNMT (0.41) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL31192159 0.75 PNMT (0.44) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL28066660 0.73 PNMT (0.49) PNMTNPC1RAB9AHTR2BGABRP
SCHEMBL27879935 0.73 PNMT (0.53) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL28989984 0.72 PNMT (0.47) PNMTNPC1RAB9AGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6693153-B2 USING COORDINATION CATALYST CALIFORNIA INSTITUTE OF TECHNOLOGY 2004-02-17 US disclosed
US-20030139544-A1 Catalyst system for the polymerization of alkenes to polyolefins ENERGY, UNITED STATES DEPARTMENT OF 2003-07-24 US disclosed
US-6469188-B1 CATALYST SYSTEMS PARTICULARLY USEFUL FOR THE POLYMERIZATION OF POLYPROPYLENE TO GIVE ELASTOMERIC POLYPROPYLENES CALIFORNIA INSTITUTE OF TECHNOLOGY 2002-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139544-A1 Catalyst system for the polymerization of alkenes to polyolefins MSH2, PMS2, SDC4 PNMT 337/4885NPC1 4815/4885RAB9A 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.